Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001344437 | SCV001538490 | uncertain significance | not provided | 2022-08-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1763Leufs*33) in the TUBGCP6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 57 amino acid(s) of the TUBGCP6 protein. This variant is present in population databases (rs775659848, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TUBGCP6-related conditions. ClinVar contains an entry for this variant (Variation ID: 1040743). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001344437 | SCV003805013 | likely pathogenic | not provided | 2022-08-08 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation, as the last 57 amino acids are replaced with 32 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Center for Genomic Medicine, |
RCV003493847 | SCV004242512 | uncertain significance | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing |